An interventional study of Algorithm: Uniform Sampling and Algorithm: hbMEP-adaptive algorithm (version 1) in Modeling of Recruitment Curves, sponsored by Columbia University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Columbia University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are critical for monitoring the state of the nervous system during therapies like transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS).
This study tests a new, real-time computational approach based on our previously developed methods (Hierarchical Bayesian models) to estimate these recruitment curves more efficiently. The primary goal is to use this model to dynamically guide the experiment, automatically selecting the optimal stimulation intensities to test.
The investigators hypothesize that this optimized approach will accurately estimate the entire recruitment curve, or specific targets components of it like the motor threshold, using significantly fewer samples than standard methods. By reducing the number of measurements required, this approach aims to decrease experimental time and minimize participant burden, making future TMS and SCS therapies and experiments more feasible and efficient.
Transcranial magnetic stimulation and other types of neurostimulation play a crucial role in advancing the understanding and manipulation of neural activity for both research and therapeutic purposes. The proposed approach to sampling recruitment curves in real-time promises to significantly improve the efficiency and precision of experiments that use electrical or electromagnetic stimulation techniques, reducing the experimental burden for participants as well as experimenters. By enhancing experimental efficiency in multiple experimental settings and techniques, this research directly contributes to accelerating the translation of scientific discoveries into clinical applications. This study will benchmark the relative performance of different methods against each other by testing existing and proposed algorithms using neurostimulation in people, and comparing the resultant estimates in recruitment curve parameters, and the number of samples required to reach predefined tolerances on these parameters.
Columbia University is the lead sponsor of 1,136 studies on the registry; 194 are open to participants now.
Of its 182 completed or terminated interventional studies of FDA-regulated products, 150 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants undergo distinct experiments within a single session to compare different neurostimulation sampling algorithms. Each experiment involves recruitment curve sampling with different methods (e.g., Uniform, Expected Information Gain) to evaluate the accuracy and efficiency of motor threshold.
Other: Algorithm: Uniform Sampling · Other: Algorithm: hbMEP-adaptive algorithm (version 1) · Other: Algorithm: hbMEP-adaptive algorithm (version 2) · Other: ML-PEST · Device: MagPro X100 Transcranial Magnetic Stimulation · Device: Digitimer DS8R Transcutaneous Electrical stimulation
Standard uniform distribution sampling used as a baseline comparison.
An active sampling algorithm for recruitment curve estimation.
An alternative active sampling algorithm for recruitment curve estimation.
Algorithm: Adaptive threshold hunting using the Parameter Estimation by Sequential Testing (PEST) algorithm.
The proposed algorithms will deliver stimulation by using this magnetic stimulation methodology.
The proposed algorithms will deliver stimulation by using this electrical stimulation methodology.
Number of stimuli to reach a pre-defined threshold error
Number of stimuli required for the compared methods to reach a pre-defined error threshold relative to the ground truth, computed from recruitment curves fitted after sampling using aggregated data.
Time frame: Through completion of the study visit, 2-4 hours.
Number of stimuli to reach a pre-defined predictive curve error
Number of stimuli required for the compared methods to reach a pre-defined error threshold relative to the ground truth, computed from recruitment curves fitted after sampling using aggregated data.
Time frame: Through completion of the study visit, 2-4 hours.
Mean absolute error in a given parameter (e.g. threshold, predictive curve, slope) for a given number of stimuli
The error of the methods under comparison, with the ground truth computed from recruitment curves fitted subsequent to sampling using aggregated data.
Time frame: Through completion of the study visit, 2-4 hours.
Plan to share: Yes — De-identified MEP data and analysis code and algorithms.
Supporting information: Analytic code
Time frame: Together with publication at the end of this study (04/2027).
Access criteria: Open access repository (e.g. Zenodo and Github).
Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.